Idiopathic Pulmonary Fibrosis behavior in the aged population- is it different?

O. Hakrush (Haifa, Israel), S. Schneer (Haifa, Israel), Y. Adir (Haifa, Israel)

Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis

Session: Clinical aspects of idiopathic pulmonary fibrosis
Session type: E-poster session
Number: 763

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Hakrush (Haifa, Israel), S. Schneer (Haifa, Israel), Y. Adir (Haifa, Israel). Idiopathic Pulmonary Fibrosis behavior in the aged population- is it different?. 763

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016 Year: 2017
What can we learn from Idiopathic Pulmonary Fibrosis Registries? Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018
Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019
Impact of depression on patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017
Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
IPF - Idiopathic Pulmonary Fibrosis Source: Breathe, 15 (2) 153; 10.1183/20734735.ELF152 Year: 2019
Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015
The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018
Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017
Potential benefits of Nordic Walking for Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019
Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019
Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018
Idiopathic Pulmonary Fibrosis (IPF) Source: ERS Courses: Interstitial Lung Diseases Year: 2019
Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014
Idiopathic Pulmonary Fibrosis: mortality trends in Chile Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis? Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020
Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort Source: International Congress 2014 – ILDs 4 Year: 2014
Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017
Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary Source: Guideline 2015 Year: 2015